country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Country or Region:

United States

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

Cat. No.: HY-183292

Copy Link Print Information

SH-1092

SH-1092 is an orally active EGFR inhibitor with an IC₅₀ of 0.96 nM against EGFR^T790M/L858R and an IC₅₀ of 6.1 nM against wild-type EGFR. SH-1092 exhibits anticancer activity against non-small cell lung cancer. SH-1092 can be used in studies related to non-small cell lung cancer.

연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.

화학식: C₃₀H₃₅N₇O₃
분자량:541.64

보관:

Please store the product under the recommended conditions in the Certificate of Analysis.

SH-1092 Chemical Structure

Amount: USD 0.00

* 장바구니에 담기 전 물품의 수량을 선택해 주십시오.

Use of MCE Products

One-stop solution for XDC (ADC/PDC/RDC/ApDC/FDC/ISAC/VDC/SMDC)

Biological Activity
- 제품 설명
- IC₅₀ & Target
- In Vitro
- Parmacokinetics
- In Vivo
Chemical Information
순도&문서
References
Calculators
Help & FAQs
Classifications
Bioz

Biological Activity

제품 설명

IC₅₀ & Target

^[1]

EGFR^L858R/T790M

0.96 nM (IC₅₀)

EGFR (WT)

EGFR nM (IC₅₀)

All EGFR Isoforms :

In Vitro

SH-1092 potently inhibits EGFR^T790M/L858R with an IC₅₀ of 0.96 nM; it also inhibits wild-type EGFR with an IC₅₀ of 6.1 nM, exhibits moderate selectivity for the mutant form, and shows weak inhibitory effects on IGF1R and INSR^[1].
SH-1092 (0.1 nM-10 μM; 72 h) inhibits the proliferation of H1975 (EGFR^T790M/L858R) cells and A431 (wild-type EGFR) cells^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Proliferation Assay^[1]

Cell Line:

H1975 (EGFR T790M/L858R mutant) non-small cell lung cancer cell line, A431 (EGFR wild-type) non-small cell lung cancer cell line
Concentration:

0.1 nM-10 μM
Incubation Time:

72 h
Result:

Inhibited the growth of H1975 cells with an IC₅₀ of 8 nM.
Inhibited the growth of A431 cells with an IC₅₀ of 362 nM.

Parmacokinetics

Species	Dose	Route	T_1/2	AUC_0-t	AUC_0-∞	CL	T_max	F
Mice^[1]	1.25 mg/mL	p.o.	2.7 h	1062 ng·h/mL	1092.9 ng·h/mL	/	0.8 h	19.8 %
Mice^[1]	0.2 mg/mL	i.v.	0.5 h	429.1 ng·h/mL	429.4 ng·h/mL	4.9 L/h/kg	/	/

In Vivo

SH-1092 (25-50 mg/kg; p.o.; daily; 14 days) exhibits dose-dependent, significant antitumor activity against EGFR wild-type A431 NSCLC xenografts in female BALB/c nude mice with low acute toxicity^[1].
SH-1092 (10-50 mg/kg; p.o.; daily; 14 days) exhibits dose-dependent, significant antitumor activity against EGFR^T790M/L858R mutant H1975 NSCLC xenografts in female BALB/c nude mice with low acute toxicity^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:

BALB/c nude (female)^[1]
Dosage:

25 mg/kg; 50 mg/kg
Administration:

p.o.; daily; 14 days
Result:

Significantly inhibited A431 xenograft tumor growth in a dose-dependent manner.
Did not change mouse body weight significantly during treatment, indicating low acute toxicity.

Animal Model:

BALB/c nude (female)^[1]
Dosage:

10 mg/kg; 25 mg/kg; 50 mg/kg
Administration:

p.o.; daily; 14 days
Result:

Significantly inhibited H1975 xenograft tumor growth in a dose-dependent manner.
Did not change mouse body weight significantly during treatment, indicating low acute toxicity.

Chemical Information

분자량 541.64
화학식 C₃₀H₃₅N₇O₃
SMILES

C=CC(NC1=CC(NC2=NC=C(C)C(C3=CN4C5=C3C=CC=C5OCC4)=N2)=C(OC)C=C1N(CCN(C)C)C)=O
선적

Room temperature in continental US; may vary elsewhere.
보관

Please store the product under the recommended conditions in the Certificate of Analysis.

순도&문서

Handling Instructions (2659 KB)

References

[1]. Liu K, et al. Discovery and development of the preclinical candidate (SH-1092), a potent third generation EGFR inhibitor for the treatment of NSCLC. Bioorg Chem. 2026;176:109884. [Content Brief]

Calculators

몰농도 계산기

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Concentration Concentration

Volume Volume

Molecular Weight Molecular Weight

농도 희석 계산기

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

Concentration _(start) Concentration _(start)

Volume _(start) Volume _(start)

Concentration _(final) Concentration _(final)

Volume _(final) Volume _(final)

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Bioz

Keywords

MOQ

Minimum order quantity

100 mg

견적 받기 해외재고보유

Other size

견적 받기